Controlled Substances

Apex Molecular Ltd operate with a Precursor and Controlled Drugs Licence, allowing us to synthesise and store all scheduled substances for use in research projects.

Below are a list of controlled substances, metabolites and stable isotopically labelled (SIL) compounds available for purchase directly from Apex Molecular Ltd. We have extensive experience in the synthesis of psychoactive compounds such as tryptamines, phenylamines and lysergic acid analogues. Other quantities and compounds can be synthesised on request.

All compounds are synthesised in Apex Molecular’s UK laboratories.

Worldwide shipping is standard and available with an easy to follow process, handled by our logistics experts.

Psychoactive Compounds

Tryptamines

Structure	Name	CAS	Spec	Quantity
	Psilocin 4-hydroxy-N,N-dimethyltryptamine	520-53-6	>95%	50 mg 100 mg 200 mg 500 mg
	Nor-Psilocin	28363-70-4	>95%	50 mg 100 mg 200 mg 500 mg
	Psilocybin 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate	520-52-5	>95%	50 mg 100 mg 200 mg 500 mg
	Baeocystin (N-desmethylpsilocybin)	21420-58-6	>95%	50 mg 100 mg 200 mg 500 mg
	4-HTP 3-(2-Hydroxyethyl)-4-indolol	1379213-90-7	>95%	50 mg 100 mg 200 mg 500 mg
	4-HIAA (4-Hydroxy-3-indolyl)acetic acid	56395-08-5	>95%	50 mg 100 mg 200 mg 500 mg

Metabolites and Stable Isotopically Labelled Tryptamines

Structure	Name	CAS	Spec	Quantity
	Psilocin-O-glucuronide 6-{3-[2-(Dimethylamino)ethyl]-4-indolyloxy}-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid	514212-83-0	>95%	50 mg 100 mg 250 mg Bulk
	Psilocin-O-glucuronide-d4 6-{3-[2-(Dimethylamino)(²H₄)ethyl]-4-indolyloxy}-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid		>95%	10 mg 25 mg 50 mg Bulk
	Psilocin-d4 3-[2-(Dimethylamino)(²H₄)ethyl]-4-indolol	1286546-49-3	>95%	50 mg 100 mg 200 mg 500 mg
	Psilocybin-d4 3-[2-(Dimethylamino)(²H₄)ethyl]-4-indolyl dihydrogen phosphate	1246819-43-1	>95%	50 mg 100 mg 200 mg 500 mg
	Nor-Psilocin-d4 3-[2-(Methylamino)(²H₄)ethyl]-4-indolol	2742678-87-9	<95%	50 mg 100 mg 200 mg 500 mg

Cannabinoids

Structure	Name	CAS	Spec	Quantity
	Δ8-THC 6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol	5957-75-5	>95%	10 mg 25 mg 50 mg
	∆8-THC-acid (−)-11-nor-9-carboxy-Δ8-THC	39690-06-7	>95%	10 mg 25 mg 50 mg
	11-hydroxy-Δ8-THC (6aR,10aR)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-methanol	28646-40-4	>95%	10 mg 25 mg 50 mg
	11-hydroxy-Δ8-THC-d3 6aR,7,10,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-3-(pentyl-5,5,5-d3)-6H-dibenzo[b,d]pyran-9-carboxylic acid	949596-06-9	>95%	1 mg 5 mg
	Δ9-THC 6aR,7,8,10aR-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol	1972-08-3	>95%	10 mg 25 mg 50 mg
	∆9-THC-acid (6aR,10aR)-rel-6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-carboxylic acid	104874-50-2	>95%	10 mg 25 mg 50 mg
	11-hydroxy-Δ9-THC 6aR,7,8,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6H-dibenzo[b,d]pyran-9-methanol	36557-05-8	>95%	10 mg 25 mg 50 mg
	Δ9-THC-d3 (4aR,10aR)-3,10,10-Trimethyl-7-[(5,5,5-²H₃)pentyl]-2,4a,10,10a-tetrahydro-1H-9-oxaphenanthren-5-ol	81586-39-2	>95%	10 mg 25 mg 50 mg
	Δ9-THC-d9 (4aR,10aR)-3,10,10-Trimethyl-7-[(2,2,3,3,4,4,5,5,5-²H₉)pentyl]-2,4a,10,10a-tetrahydro-1H-9-oxaphenanthren-5-ol		>95%	10 mg 25 mg 50 mg

	Cannabinol (CBN) 3,10,10-Trimethyl-7-pentyl-10H-9-oxaphenanthren-5-ol	521-35-7	>95%	10 mg 25 mg 50 mg

	Cannabidiol (CBD)	13956-29-1	>95%	50 mg 100 mg 200 mg 500 mg

Ketamine and metabolites

Ketamine	6740-88-1	>95%	50 mg 100 mg 200 mg 500 mg
Norketamine	35211-10-0	>95%	50 mg 100 mg 200 mg 500 mg
Hydroxy-NorKetamine	81395-70-2	>95%	10 mg 25 mg 50 mg
Dehydronorketamine	57683-62-2	>95%	10 mg 25 mg 50 mg